MedPath

PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMI

Conditions
Acute myocardial infarction
MedDRA version: 9.1Level: LLTClassification code 10064346Term: STEMI
Registration Number
EUCTR2008-001325-34-IT
Lead Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Age > 18 y
2.Acute myocardial infarction (STEMI) with ST segment elevation in at least two contiguous leads and thoracic pain lasting over 20 minutes and less than 6 hours
3.Informed Consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1.Acute myocardial infarction without ST elevation (NSTEMI)
2.Complete left bundle branch block
3.Previous STEMI in the same territory
4.Contraindications to anti-platelet therapy or IIb/IIIa inhibitors
5.Hypertension (> 180/100 mmHg)
6.Pregnancy or fertile age

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: This pilot phase has the purpose to evaluate the effectiveness of Iloprost in terms of increase of the percentage of patients with complete ST resolution (primary endpoint).;Secondary Objective: The improvement of the result of coronary angioplasty will be measured by the reduction of ST segment elevation, expression of transmural ischemia characterizing acute myocardial infarction. In respect to the control group, to be considered effective Iloprost should increase the number of patients with ?complete resolution? of ST segment elevation 90 minutes after stent implantation.;Primary end point(s): ST resolution 90 min after the vessel recanalization
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath